drugset / Trial / NCT01326858
Safety and Comfort of AL-4943A Ophthalmic Solution
RandomizedCrossoverDouble-blind
Summary
The purpose of this study is to assess the ocular comfort and safety of olopatadine hydrochloride opthalmic solution. 0.7%.
Timeline
- Start
- 2011-04
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketotifen | Small molecule | 0.025 % | Other |
| Subject | Olopatadine | Other / unclassified | 0.7 % | Other |